[Clinical aspects of temporal arteritis: course variations up to fatal complications].
BACKGROUND
Arteritis temporalis (AT) shows a variable course of the disease and may lead to transient or permanent visual loss.


METHODS
In a retrospective consecutive case series 66 patients with suspected AT were followed up of which 65 underwent arterial biopsy. Symptoms, therapy and complications were followed up.


RESULTS
Of the patients 32 (49.2%) revealed a positive histological finding in unilateral (55.4%) or bilateral (44.6%) biopsy. Of these 3 (9.4%) suffered a severe or fatal outcome: two with extensive ischemia of the vertebrobasilar system (one fatal) and one patient died due to acute pancreatitis, a rare side effect of systemic steroid therapy.


CONCLUSIONS
When systemically apparent, arteritis temporalis can progress to reduction of general health, cerebral ischemia and organ infarction. Therefore, AT is a serious disease requiring interdisciplinary, immediate diagnostics and prompt therapy.
Brüggemann
A
A
Klinik für Augenheilkunde, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Deutschland, anne.brueggemann@uk-sh.de.
Holl-Ulrich
K
K
Müller
M
M
D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D001766:Blindness / Q000401:mortality*; D002545:Brain Ischemia / Q000401:mortality*; D015984:Causality; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D005858:Germany / Q000453:epidemiology; D013700:Giant Cell Arteritis / Q000175:diagnosis* / Q000401:mortality*; D006304:Health Status; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000401:mortality*; D015995:Prevalence; D012189:Retrospective Studies; D012307:Risk Factors; D017678:Sex Distribution; D015996:Survival Rate
Arthritis Rheum. 1999 Feb;42(2):311-7
10025926
Ophthalmologe. 2006 Apr;103(4):296-301
16552535
Arthritis Rheum. 2006 Dec 15;55(6):985-9
17139651
Clin Exp Ophthalmol. 2006 Mar;34(2):159-73; quiz 194
16626432
Ophthalmology. 2006 Oct;113(10):1842-5
16884778
Eur J Med Res. 2003 Jan 28;8(1):1-7
12578748
Neurologia. 1998 Aug-Sep;13(7):372-3
9810805
Acta Ophthalmol. 2009 Feb;87(1):13-32
18937808
Ultraschall Med. 2006 Aug;27(4):329-35
16596515
J Clin Pathol. 1993 Dec;46(12):1129-31
8282839
J Neuroophthalmol. 2000 Sep;20(3):213-5
11001197
Neurology. 1988 Mar;38(3):352-9
3347337
Ophthalmology. 2009 Aug;116(8):1574-80
19500846
Autoimmun Rev. 2004 Jan;3(1):46-53
14871649
Arthritis Rheum. 2004 Apr 15;51(2):264-8
15077270
JAMA. 1993 Apr 28;269(16):2110-2
8468765
Am J Ophthalmol. 1997 Mar;123(3):285-96
9063237
Am J Ophthalmol. 1998 Apr;125(4):521-6
9559738
Rheum Dis Clin North Am. 2001 Nov;27(4):781-97, vi
11723764
Dtsch Arztebl Int. 2008 May;105(19):355-61
19629246
Ann Intern Med. 2003 Sep 16;139(6):505-15
13679329
Am J Clin Pathol. 1978 Mar;69(3):299-305
637044
Medicine (Baltimore). 2003 Jan;82(1):1-12
12544706
Arthritis Res Ther. 2006;8(4):R116
16859533
Curr Opin Ophthalmol. 2007 Nov;18(6):443-9
18162994
J Med Case Rep. 2008 Nov 17;2:346
19014625
Cerebrovasc Dis. 2007;24(2-3):226-30
17630482
Arthritis Rheum. 2003 Apr;48(4):1159-60; author reply 1160-1
12687562